Managing Overnight Hypoglycemia

Immediate Treatment of Nocturnal Hypoglycemia

• Administering 15-20 grams of glucose using glucose tablets or carbohydrate-containing foods/beverages is recommended for immediate treatment of nocturnal hypoglycemia, and blood glucose should be rechecked 15-20 minutes after treatment; if levels remain low, the glucose dose should be repeated, according to the American Diabetes Association 1
• For patients taking α-glucosidase inhibitors, using monosaccharides such as glucose tablets is specifically recommended, as these drugs prevent digestion of polysaccharides, as suggested by the American Diabetes Association 1, 2

Prevention Strategies: Insulin Regimen Optimization

• Switching to longer-acting basal analogs, such as U-300 glargine or degludec, can reduce nocturnal hypoglycemia risk, as they convey the lowest nocturnal hypoglycemia risk compared to U-100 glargine or NPH insulin, according to the American Diabetes Association 3
• Evaluating for overbasalization, which is a common cause of nocturnal hypoglycemia, is crucial, and signs include nocturnal hypoglycemia, high glucose variability, and basal dose >0.5 units/kg, as indicated by the American Diabetes Association 3

Prevention Strategies: Behavioral and Monitoring Approaches

• Consuming a source of carbohydrates at bedtime can reduce overnight hypoglycemia risk, and moderate amounts of carbohydrates at each meal and snacks can help maintain stable glucose levels, as recommended by the American Diabetes Association 2
• If consuming alcohol, it should always be taken with food, as alcohol increases hypoglycemia risk in patients on insulin or insulin secretagogues, according to the American Diabetes Association 2
• Adjusting the timing of basal insulin administration to avoid peak insulin action during sleep hours, and adjusting the dose of mealtime insulin if physical activity occurs within 1-2 hours of mealtime, can help reduce hypoglycemia risk, as suggested by the American Diabetes Association 1, 2

Managing Nocturnal Hypoglycemia in Diabetes

Prevention Strategies

• The American Diabetes Association recommends using automated insulin delivery (AID) systems with continuous glucose monitoring (CGM) and predictive low-glucose insulin suspension features to significantly reduce nocturnal hypoglycemic events while maintaining glycemic control 4
• The use of shorter-duration rapid-acting analog insulins may lead to a greater risk of nocturnal hypoglycemia 4
• Impaired counterregulatory responses, especially in patients with long-standing diabetes, can contribute to nocturnal hypoglycemia 5
• Continuous Glucose Monitoring (CGM) with alarms can improve glycemic outcomes and decrease hypoglycemic events 4
• Sensor-augmented insulin pumps with threshold-suspend features can reduce nocturnal hypoglycemia without increasing HbA1c values 6
• Long-acting basal analogs (glargine, detemir) can reduce the risk of nocturnal hypoglycemia compared to NPH insulin 4, 7
• Newer longer-acting basal analogs (U-300 glargine or degludec) can convey even lower nocturnal hypoglycemia risk 8
• Adjusting the timing and dosing of insulin, such as converting to twice-daily NPH regimen with appropriate dose adjustments, can help prevent nocturnal hypoglycemia 9, 10
• Evaluating for overbasalization (high bedtime-to-morning glucose differential >50 mg/dL) and adjusting accordingly can help prevent nocturnal hypoglycemia 8
• Reducing evening/bedtime insulin doses by 10-20% can help prevent nocturnal hypoglycemia in high-risk patients 10
• Analyzing patterns of nocturnal hypoglycemia is crucial for regimen optimization 4

Nocturnal Hypoglycemia Management in Insulin Pump Therapy

Basal Rate Adjustments and Monitoring

• The American Diabetes Association recommends adjusting basal insulin every 3 days based on patterns, not isolated readings, and monitoring fasting blood glucose for at least 3 consecutive nights before making additional basal rate changes 11
• Basal insulin typically represents 40-60% of total daily insulin dose in pump therapy, with the remainder as mealtime and correction boluses, and if total daily basal delivery exceeds 50-60% of total daily dose, this suggests overbasalization and increases nocturnal hypoglycemia risk 11
• Calculate the 24-hour basal rate total from the pump menu and compare it to the total daily insulin dose to assess basalization 12

Prevention Strategies and Advanced Technology

• Consider using the temporary basal rate feature to reduce overnight insulin delivery by 10-50% on nights following intense physical activity, as recommended by the American Diabetes Association 11, 13
• If nocturnal hypoglycemia persists despite basal rate adjustments, sensor-augmented pump therapy with automatic low glucose suspend should be considered, as this technology can prevent or mitigate hypoglycemic episodes 14
• Real-time CGM with alarms significantly improves detection of nocturnal hypoglycemia, which is underestimated 40-60% of the time with fingerstick monitoring, and automated insulin delivery systems have their particular strength in nocturnal glucose regulation 13, 14

Carbohydrate Ratio and Correction Factor Considerations

• The carbohydrate-to-insulin ratio determines how much insulin covers dietary carbohydrates and should only be adjusted if post-meal glucose readings are consistently out of target, as per the British Journal of Anaesthesia guidelines 11
• The insulin sensitivity factor (correction factor) addresses pre-meal hyperglycemia and should only be changed if correction doses consistently fail to bring glucose into target range, according to the British Journal of Anaesthesia guidelines 11

Common Pitfalls to Avoid

• Do not wait for multiple episodes of nocturnal hypoglycemia before adjusting basal rates, as recurrent hypoglycemia can lead to hypoglycemia unawareness and impaired counterregulatory responses, as emphasized by the American Diabetes Association 15
• Avoid "stacking" correction doses in the evening, as the pump's insulin-on-board calculator should prevent this, but manual overrides can lead to nocturnal hypoglycemia, as warned by the British Journal of Anaesthesia guidelines 11

Nocturnal Hypoglycemia Management

Advanced Technology Solutions

• The American Diabetes Association recommends adjusting basal insulin every 3 days based on documented patterns, and sensor-augmented pump therapy with automatic low glucose suspend can reduce nocturnal hypoglycemia by 31.8% without increasing HbA1c values, as seen in patients with type 1 diabetes 16, 17
• Sensor-augmented pump therapy with threshold suspend can prevent hypoglycemia in 75% of nights (84% of individual events) when it would otherwise occur, and decrease the area under the curve for nocturnal hypoglycemic events by 37.5% in patients using continuous glucose monitoring 16, 17

Management of Nocturnal Hypoglycemia

Diagnostic Approach and Insulin Adjustments

• Despite recognition of hypoglycemia, 75% of patients do not have their basal insulin adjusted before the next administration, which is a critical error to avoid, according to the American Diabetes Association 18, 19
• The incidence of hypoglycemia peaks between midnight and 6:00 AM, yet 78% of patients experiencing hypoglycemia are using basal insulin without appropriate dose adjustments, highlighting the need for careful basal insulin management, as recommended by the American Diabetes Association 18, 19